Mercy and Johnson & Johnson Medical Devices Companies (JJMDC) recently announced a collaboration in which Mercy’s data platform will be used to evaluate the efficacy and safety of JJMDC devices.

“With more than 8,000 new medical devices entering the market each year, it’s critical that we find better ways to evaluate their performance,” said Dr. Joseph Drozda, director of outcomes research at Mercy.

You can access the full press release here.